See more : Exro Technologies Inc. (1O2.F) Income Statement Analysis – Financial Results
Complete financial analysis of BioNano Genomics, Inc. WT EXP 082123 (BNGOW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BioNano Genomics, Inc. WT EXP 082123, a leading company in the industry within the sector.
You may be interested
- Platina Resources Limited (PTNUF) Income Statement Analysis – Financial Results
- Dee Tech S.A. (DEE.PA) Income Statement Analysis – Financial Results
- Longfor Group Holdings Limited (0960.HK) Income Statement Analysis – Financial Results
- CAVA Group, Inc. (CAVA) Income Statement Analysis – Financial Results
- Danske Invest Euro HY-Obl – Akk (DKIEUHYOAKKDKKH.CO) Income Statement Analysis – Financial Results
BioNano Genomics, Inc. WT EXP 082123 (BNGOW)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 36.12M | 27.80M | 17.98M | 8.50M | 10.13M | 12.00M | 9.51M | 6.79M |
| Cost of Revenue | 26.55M | 21.86M | 14.11M | 5.73M | 6.77M | 8.71M | 6.03M | 3.58M |
| Gross Profit | 9.57M | 5.95M | 3.87M | 2.77M | 3.36M | 3.29M | 3.47M | 3.21M |
| Gross Profit Ratio | 26.49% | 21.38% | 21.54% | 32.61% | 33.18% | 27.41% | 36.55% | 47.32% |
| Research & Development | 54.03M | 49.05M | 22.49M | 10.26M | 9.08M | 9.48M | 12.01M | 11.43M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.22M | 14.08M | 12.95M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 94.96M | 88.60M | 58.49M | 31.07M | 20.16M | 14.22M | 14.08M | 12.95M |
| Other Expenses | 75.82M | -223.00K | -59.00K | -2.56M | -3.94M | -675.85K | -289.01K | -203.29K |
| Operating Expenses | 224.81M | 137.64M | 80.98M | 41.32M | 29.24M | 23.70M | 26.09M | 24.38M |
| Cost & Expenses | 251.36M | 159.50M | 95.08M | 47.05M | 36.00M | 32.42M | 32.12M | 27.96M |
| Interest Income | 3.31M | 1.51M | 236.00K | 2.52M | 2.29M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.12M | 298.00K | 927.00K | 2.52M | 2.29M | 1.38M | 590.93K | 470.07K |
| Depreciation & Amortization | 13.71M | 10.10M | 3.97M | 1.47M | 1.13M | 1.32M | 1.50M | 1.12M |
| EBITDA | -213.60M | -120.32M | -73.86M | -37.08M | -26.38M | -15.78M | -21.25M | -17.25M |
| EBITDA Ratio | -591.44% | -469.08% | -427.81% | -453.39% | -255.44% | -175.75% | -225.14% | -298.21% |
| Operating Income | -215.25M | -131.70M | -77.10M | -38.55M | -25.87M | -20.42M | -23.22M | -21.17M |
| Operating Income Ratio | -595.98% | -473.70% | -428.79% | -453.39% | -255.44% | -170.12% | -244.28% | -311.63% |
| Total Other Income/Expenses | -17.19M | 986.00K | -1.05M | -2.53M | -3.92M | 1.93M | -128.00K | 2.33M |
| Income Before Tax | -232.43M | -130.71M | -78.15M | -41.11M | -29.82M | -18.48M | -23.35M | -18.84M |
| Income Before Tax Ratio | -643.57% | -470.15% | -434.64% | -483.43% | -294.34% | -154.00% | -245.63% | -277.29% |
| Income Tax Expense | 62.00K | 1.88M | -5.72M | 29.19K | 21.05K | 15.51K | 18.55K | 12.92K |
| Net Income | -232.49M | -132.60M | -72.44M | -41.14M | -29.84M | -18.50M | -23.37M | -18.85M |
| Net Income Ratio | -643.74% | -476.93% | -402.84% | -483.78% | -294.55% | -154.13% | -245.82% | -277.48% |
| EPS | -6.81 | -4.58 | -2.62 | -3.95 | -19.92 | -26.14 | -86.50 | -36.06 |
| EPS Diluted | -6.81 | -4.58 | -2.62 | -3.95 | -19.92 | -26.14 | -86.50 | -36.06 |
| Weighted Avg Shares Out | 34.15M | 28.92M | 27.68M | 10.43M | 1.50M | 707.71K | 270.11K | 522.74K |
| Weighted Avg Shares Out (Dil) | 34.15M | 28.92M | 27.68M | 10.43M | 1.50M | 707.71K | 270.11K | 522.74K |
No news found for: BNGOW
Source: https://incomestatements.info
Category: Stock Reports